Financials
Financial year 2024
Worth noting
- Little cash and receivables against the short-term debts.
Gross margin
€ 917,755
▲ 57% vs 2023
Profit
Healthy€ 259,803
▼ 3% vs 2023
Debts
High€ 4.5 million
▲ 7% vs 2023
GOODLIFE PHARMA from Chastre, company number BE0845590372, closed financial year 2024 with a result of € 259,803 after tax. For that financial year GOODLIFE PHARMA recorded a gross margin of € 917,755 and equity of € 649,802. Compared with financial year 2023, the result moved from € 268,956 to € 259,803. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2025.
What happened at GOODLIFE PHARMA?
What happened at GOODLIFE PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 259,803 (▼ 3% vs 2023). Source: NBB ↗
- Sterq Management BV became a director. NBB
- LMW Management BV stepped down as director. NBB
- LMW Management BV became a director. NBB
- Nathalie Schewebach became a director. NBB
- New establishment in Chastre. KBO
- Start of the company according to the CBE. KBO
In short
From € 81,668 profit in 2021 to € 259,803 profit in 2024.
Paid € 94,642 in corporate taxes since 2021.
Best year ever: 2023, with € 268,956 profit.
On average € 339,900 of value added per employee in 2024.
A new publication or filing at GOODLIFE PHARMA? We notify you, reason included.
Follow GOODLIFE PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind GOODLIFE PHARMA are Nathalie Schewebach and Sterq Management BV.
Directors
According to the 2024 annual accounts
Nathalie Schewebach
Director
since 2023
Sterq Management BV
Managing director · represented by Koen Perenboom
since 2024
Managing director · represented by Lucy Megens
since 2023 · until 2024
Establishments
Establishment units
Physical locations of this company
Rue François-Massart 27
1450 Chastre
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0845.590.372
- VAT number
- BE 0845.590.372
- Registered office
- Rue François-Massart 27, 1450 Chastre
- Names & denominations
- GOODLIFE PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 11 April 2012
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Detailhandel in farmaceutische producten
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels